Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Medtronic; Edwards Lifesciences; W.L. Gore & Associates; philips; Jenavalve; Johnson & Johnson; Anteris; Avania